1.Mechanistic study on the solubility enhancement of puerarin by coamorphous technology
Xiu-juan WU ; Zun-ting PANG ; Si-tong YANG ; Meng-meng YAN ; Yuan GAO
Acta Pharmaceutica Sinica 2021;56(2):585-592
Puerarin (PUE), as an isoflavone component, has a wide range of pharmacological activities, while its poorly aqueous solubility limits the development of solid oral dosage forms. In this study, PUE along with nicotinamide (NIC) were prepared into the coamorphous system by solvent-evaporation method and characterized by powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC) and Fourier transform infrared spectroscopy (FT-IR). In addition, its dissolution behavior and solubilization mechanism were also investigated. PUE-NIC coamorphous was a single homogeneous binary system, with a single glass transition temperature at 35.1 ℃. In comparison to crystalline PUE, during the dissolution process, coamorphous PUE-NIC not only exhibited the "liquid-liquid phase separation" (LLPS) phenomenon, but the formation of Ap type complexation (1∶1 and 1∶2) between PUE and NIC molecules was also verified, which significantly improved the solubility of PUE and prolonged the supersaturation time, and would benefit its absorption.
2.Application of cocrystal separation technology in the separation and purification of genistein-puerarin-daidzein ternary system
Xue-ming LI ; Yan LU ; Shuai QIAN ; Zun-ting PANG ; Yuan-feng WEI
Acta Pharmaceutica Sinica 2023;58(2):439-446
Cocrystal separation technology is a technology that utilizes coformers to selectively form cocrystals with target compounds and separate them from mixed systems. Our study used puerarin (PUE), daidzein (DDZ), and genistein (GEN) as model drugs, which have similar structures and are the main isoflavones in
3.Druggability enhancement by modification of physicochemical properties of drugs via crystal engineering
Xing-ye WENG ; Zun-ting PANG ; Shuai QIAN ; Yuan-feng WEI ; Yuan GAO ; Jian-jun ZHANG
Acta Pharmaceutica Sinica 2020;55(12):2883-2891
The solubility/dissolution, hygroscopicity and mechanical properties of drug candidates have a profound effect on oral bioavailability, processability and stability. The physicochemical properties of crystalline drug are closely related to inner crystal structure. Crystal engineering technologies, as strategies of altering the crystal structure and tailoring physicochemical properties at molecular level, possess the potential of enhancing the pharmaceutical performance of product. The current article reviewed the modification of drug solubility/dissolution, hygroscopicity and mechanical properties by crystal engineering technologies through polymorphic selection, amorphization/co-amorphization, as well as co-crystallization, which provided a reference for the applications of pharmaceutical crystallography in improving physicochemical properties and druggability.